Cargando…
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study
BACKGROUND: Indolent systemic mastocytosis (ISM) is a rare, clonal mast cell neoplasm characterized by severe, unpredictable symptoms. The Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) items compose a Total Symptom Score (TSS), Gastrointestinal Symptom Score (GSS), and Skin Sympto...
Autores principales: | Padilla, Brad, Shields, Alan L., Taylor, Fiona, Li, Xiaoran, Mcdonald, Jeffrey, Green, Tanya, Boral, Anthony L., Lin, Hui-Min, Akin, Cem, Siebenhaar, Frank, Mar, Brenton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522163/ https://www.ncbi.nlm.nih.gov/pubmed/34663404 http://dx.doi.org/10.1186/s13023-021-02037-3 |
Ejemplares similares
-
Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF(©)
por: Taylor, Fiona, et al.
Publicado: (2021) -
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF(©)) and determination of a threshold score for moderate symptoms
por: Shields, Alan L., et al.
Publicado: (2023) -
Efficacy of Omalizumab in Indolent Systemic Mastocytosis
por: Slapnicar, Calum, et al.
Publicado: (2019) -
Treatment of Indolent and Advanced Systemic Mastocytosis
por: Buonomo, Alessandro, et al.
Publicado: (2022) -
Indolent systemic mastocytosis in a patient with ileocolitis
por: Chrysakopoulos, Georgios, et al.
Publicado: (2014)